glp 1 drugs and ulcerative colitis GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations Practical Recommendations for Safe and Effective Use | Current Obesity Reports GLP-1s and Ulcerative Colitis: Safety

The Bottom Line The appeal of needle-free GLP-1 options is understandable, but the current evidence does not support sublingual semaglutide drops or weight loss patches as effective alternatives to proven treatments

Whats your current dose

TrimRx offers compounded tirzepatide at $349 per month and compounded semaglutide at $199 per month

Look for the "preferred" or "tiered" coverage status of the GLP-1 you're interested in

But initial results were disappointing

Research indicating a link between Trulicity and severe side effects: Gastroparesis: Studies show a connection between the use of Trulicity and an increased risk of developing gastroparesis or delayed stomach emptying